IDO1 and cancer: In light of our findings that IDO conferred resistance to the BER inhibitor MX (Fig 2), we set to examined whether the presence of IDO affected the sensitivity of A549 clonal cell populations to pemetrexed, potentially linking IDO expression with enhanced BER function in cancer cells.